Actavia Life Sciences Inc (CE) (RASP)
USOTC
News
Market Data
Customized watchlists with full streaming quotes from leading exchanges, such as NASDAQ, NYSE, AMEX, OTC Markets Small-Cap, LSE and more.
The current RASP market cap is 3.09M. The company's latest EPS is USD -0.0058 and P/E is 0.00.
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Revenue | 0 | 0 | 0 | 0 | 0 |
| Operating Income | -915k | -5.43M | -248k | -384k | -4.24M |
| Net Income | -936k | -5.35M | -785k | -687k | -4.44M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Total Assets | 4.95M | 33k | 45k | 85k | 96k |
| Total Liabilities | 2.41M | 2.71M | 2.71M | 1.77M | 2.05M |
| Total Equity | 2.54M | -2.68M | -2.66M | -1.69M | -1.96M |
| Year End September 29 2023 | 2019 | 2020 | 2021 | 2022 | 2023 |
|---|---|---|---|---|---|
| USD ($) | USD ($) | USD ($) | USD ($) | USD ($) | |
| Operating | -93k | -251k | -293k | -313k | -9k |
| Investing | N/A | N/A | N/A | N/A | N/A |
| Financing | 100k | 215k | 290k | 341k | 44k |
| Market Cap | 3.09M |
| Price to Earnings Ratio | 0.00 |
| Price to Sales Ratio | 0 |
| Price to Cash Ratio | 0 |
| Price to Book Ratio | 0 |
| Dividend Yield | - |
| Shares Outstanding | 771.81M |
| Average Volume (1 week) | 0 |
| Average Volume (1 Month) | 0 |
| 52 Week Change | -50.00% |
| 52 Week High | 0.039 |
| 52 Week Low | 0.0016 |
| Spread (Intraday) | 0 (0%) |
| Company Name | Actavia Life Sciences Inc (CE) |
| Address |
50 west liberty street reno, nevada 89501 |
| Website | https:// |
| Industry | pharmaceutical preparations (2834) |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
